Rosiglitazone (Avandia®) Treatment in HIV: Its Effect on Blood Vessels

NCT00143624 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

50

Enrollment

OTHER

Sponsor class

Conditions

Atherosclerosis
HIV Infections

Interventions

DRUG: Rosiglitazone maleate
DRUG: Placebo

Sponsor

University of British Columbia